Evidence in the ongoing defective product trial regarding the ASR hip replacement includes a note sent two years before the product was recalled by a doctor, who was a consultant to Johnson & Johnson, stating that the hip replacement device was defective and the company should slow its marketing of the product until the problems were worked out. Other doctors reported problems too but it appears that none spoke out publicly. Barry Meier discusses why this might have been in the New York Times: Why Doctors Remain Silent.
